Cargando…

Neurological Dysfunction Associated with Antiphospholipid Syndrome: Histopathological Brain Findings of Thrombotic Changes in a Mouse Model

The aim of this work was to study the pathological processes underlying neurological dysfunctions displayed by BALB/C mice induced with experimental antiphospholipid syndrome (APS), as we have previously reported. Experimental APS was induced in female BALB/C mice by immunization with a pathogenic m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ziporen, Lea, Polak-Charcon, Sylvia, Korczyn, D. Amos, Goldberg, Iris, Afek, Arnon, Kopolovic, Juri, Chapman, Joab, Shoenfeld, Yehuda
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2004
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275402/ https://www.ncbi.nlm.nih.gov/pubmed/15154615 http://dx.doi.org/10.1080/10446670410001670526

Ejemplares similares

Antiphospholipid Antibodies Bind ATP: A putative Mechanism for the Pathogenesis of Neuronal Dysfunction
por: Chapman, J., et al.
Publicado: (2005)

Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice
por: Katzav, Aviva, et al.
Publicado: (2013)

The infectious origin of the antiphospholipid syndrome: induction by passive transfer of anti-β2GPI antibodies induced by common bacteria
por: Blank, M, et al.
Publicado: (2003)

Antiphospholipid Syndrome and Antibodies
por: de Carvalho, Jozélio Freire, et al.
Publicado: (2014)

Perspectives on vaccine induced thrombotic thrombocytopenia
por: Dotan, Arad, et al.
Publicado: (2021)

Low Folate Levels are Associated with Strokes and Less Venous Thromboses in Primary Antiphospholipid Syndrome
por: Carvalho, Jozélio Freire, et al.
Publicado: (2022)

Significant Changes in the Levels of Secreted Cytokines in Brains of Experimental Antiphospholipid Syndrome Mice
por: Menachem, Assaf, et al.
Publicado: (2012)

Clinical Management of Thrombotic Antiphospholipid Syndrome
por: Tumian, Nor Rafeah, et al.
Publicado: (2022)

Sjögren's Syndrome Associated With Thrombotic Thrombocytopenic Purpura: A Case-Based Review
por: Carvalho, Jozélio F., et al.
Publicado: (2020)

Neuropsychiatric lupus: a mosaic of clinical presentations
por: Kivity, Shaye, et al.
Publicado: (2015)

Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome
por: Anunciación-Llunell, Ariadna, et al.
Publicado: (2022)

Urine Proteomics Differentiate Primary Thrombotic Antiphospholipid Syndrome From Obstetric Antiphospholipid Syndrome
por: Zhou, Zhuochao, et al.
Publicado: (2021)

The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome
por: Erkan, Doruk, et al.
Publicado: (2016)

Neurologic Manifestations of Autoimmune Diseases
por: Appenzeller, Simone, et al.
Publicado: (2012)

The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome
por: Rosário, Cristina, et al.
Publicado: (2013)

Catastrophic antiphospholipid antibody syndrome in a child with thrombotic microangiopathy
por: Prasad, N., et al.
Publicado: (2012)

Nonbacterial thrombotic endocarditis in a patient with primary antiphospholipid syndrome
por: Sirinvaravong, Natee, et al.
Publicado: (2018)

Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management
por: Sayar, Zara, et al.
Publicado: (2021)

Presumed antiphospholipid syndrome and thrombotic thrombocytopenic purpura: An infrequent association
por: Dolin, Hallie Hanna, et al.
Publicado: (2019)

The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome
por: Sayar, Zara, et al.
Publicado: (2022)

Impact of antiphospholipid antibodies on thrombotic events in ambulatory cancer patients
por: Kansuttiviwat, Chalermkiat, et al.
Publicado: (2023)

Recurrent Nonbacterial Thrombotic Endocarditis and Primary Antiphospholipid Antibody Syndrome
por: Mandal, Amit K, et al.
Publicado: (2023)

Neurological manifestations in patients with antiphospholipid syndrome
por: Etemadifar, Masoud, et al.
Publicado: (2013)

Neurologic Manifestations of the Antiphospholipid Syndrome — an Update
por: Leal Rato, Miguel, et al.
Publicado: (2021)

PReS-FINAL-2349: Spectrum of thrombotic and non-thrombotic manifestations in 159 children with positive antiphospholipid antibodies
por: Rozic, M, et al.
Publicado: (2013)

Close association between valvular heart disease and central nervous system manifestations in antiphospholipid syndrome
por: Krause, I, et al.
Publicado: (2005)

Catastrophic Antiphospholipid Syndrome with Severe Acute Thrombotic Microangiopathy and Hemorrhagic Complications
por: Vieregge, Gerardo B., et al.
Publicado: (2013)

Subsequent Thrombotic Outcomes in Patients with Ischemic Stroke with Antiphospholipid Antibody Positivity
por: Pyo, Jung Yoon, et al.
Publicado: (2017)

Sex Differences in Clinical Characteristics and Prognosis in Primary Thrombotic Antiphospholipid Syndrome
por: Huang, Yongfa, et al.
Publicado: (2022)

Evaluation of a gene signature related to thrombotic manifestations in antiphospholipid syndrome
por: Jacintho, Bruna Cardoso, et al.
Publicado: (2023)

Antiphospholipid Syndrome Nephropathy with Acute Thrombotic Microangiopathy after Renal Transplantation
por: Suenaga, Atsuhiko, et al.
Publicado: (2023)

Butyrate regulates E-cadherin transcription, isoform expression and intracellular position in colon cancer cells
por: Barshishat, M, et al.
Publicado: (2000)

Detection of IgA Antiphospholipid Antibodies Does not Improve Thrombotic Antiphospholipid Syndrome Classification: A two-Center Study
por: Su, Zhenzhen, et al.
Publicado: (2022)

Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults
por: Tektonidou, Maria G, et al.
Publicado: (2019)

Differences in Endothelial Activation and Dysfunction Induced by Antiphospholipid Antibodies Among Groups of Patients With Thrombotic, Refractory, and Non-refractory Antiphospholipid Syndrome
por: Velásquez, Manuela, et al.
Publicado: (2021)

Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management—An Insight into Future Approaches
por: Chighizola, Cecilia Beatrice, et al.
Publicado: (2015)

Nonbacterial Thrombotic Endocarditis of the Tricuspid Valve in a Male Patient with Antiphospholipid Syndrome
por: Yordan-Lopez, Nicole M, et al.
Publicado: (2018)

Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?
por: Siguret, Virginie, et al.
Publicado: (2020)

Antiphospholipid antibody syndrome with thrombotic splenic infarcts associated with acute cytomegalovirus infection
por: Denham, Christopher, et al.
Publicado: (2019)

Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward
por: Le Joncour, Alexandre, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4b2kiq1gqrc04folj6m6ut75uj